Skip to main content

BPCI Advanced Model Extension

Doctor with stethoscope, notes and calculator

CMS recently made several major announcements about the Bundled Payments for Care Improvement Advanced Model. 

  • The model, which was due to expire at the end of 2023 (Model Year 6), will be extended for an additional two years through Dec. 31, 2025. 
  • New applications will be accepted in 2023 for the two-year extension. Participants still active in Model Year 6 can continue without reapplying by signing an amended and restated participation agreement for Model Year 7. 
  • New methodological changes will be implemented for Model Year 6, which starts on Jan. 1, 2023. Methodological changes include that:
    • the CMS Discount Factor for medical clinical episodes will be reduced from 3% to 2%; 
    • the Peer Group Trend Factor Adjustment cap for all clinical episodes will be reduced from 10% to 5%;
    • the Major Joint Replacement of the Upper Extremity clinical episode category will become a multi-setting episode category by allowing episodes to be triggered when the procedure is performed in the hospital outpatient setting. All episodes under this clinical episode category will include additional adjustments to account for trauma and fractures; and
    • episodes that co-occur with a COVID-19 diagnosis will no longer be excluded from the model; however, the pricing methodology will include risk adjustment for when a beneficiary has a COVID-19 diagnosis during the episode. 

What do these changes mean for the BPCIA model?

Enrollment in the BPCIA model has declined over the last several years due to the expansion of risk to entire clinical episode service line groups and complex pricing methodology changes making financial goals more difficult to attain. These challenges have included the exit of major large conveners and their cohorts of downstream episode initiators. Under the new two-year extension, providers that previously participated in BPCIA will have the opportunity to reapply and providers who have not yet participated will have an opportunity to get involved. BPCIA has not had an open enrollment period since Model Year 3 in 2019 (calendar year 2020). 

New pricing methodology changes are a step in the right direction to retain enrollment of existing providers and encourage the application of non-participating providers. These changes will favor participants by reducing uncertainty in target prices, particularly as it concerns the Peer Group Trend Factor Adjustment. The inclusion of episodes when a beneficiary has a COVID-19 diagnosis will boost episode volume. It also includes fair additional risk adjustment to account for changes in episode expenditures due to the presence of a COVID-19 diagnosis. In addition, participants currently at risk for medical clinical episode categories will have higher target prices. 

There have been growing concerns about CMS’ ability to evaluate the effectiveness of this model since substantial changes in participation may result in selection bias. CMS will be able to better evaluate the impact of BPCIA by making these changes. 

What should providers do in the interim?

Current model participants can evaluate the impact of these changes compared to prior model years when evaluating their upcoming new baseline data and as Model Year 6 commences. 

Providers not currently enrolled in BPCIA should look for an announcement requesting applications from CMS in early 2023 for their chance to apply for the extension period. 

DataGen has the expertise to help providers evaluate opportunities under bundled payment arrangements and supports providers with their data analysis needs throughout the performance period. Contact us to learn more. 

Labels:

Comments

Post a Comment

Popular posts from this blog

Patient Safety Initiatives: 5 Data Factors to Know

The Surveys on Patient Safety Culture™ (SOPS®) take your hospital’s pulse. The results help answer questions like:  Are staff focused on patient safety?  What are our safety results and where can we improve?  How do we take our scores and use them to transform patient outcomes?  How do we build staff confidence?  How do we stress the importance of patient safety?  When used strategically, the required SOPS® survey data can reveal important insights — that go beyond maintaining The Joint Commission accreditation. The Agency for Healthcare Research and Quality offers data collection as a part of the SOPS® survey. Though you’re spending the resources and time to complete this requirement, this effort alone doesn’t improve patient safety. You need to know which safety initiatives to target, followed by the outcomes and impact. A deep dive into the data can deliver that.  In this blog, we'll examine five important factors that impact patient safety data and initiatives, including surve
Post a Comment
Read more

Five key components of a strong patient safety culture

In today’s healthcare environment, ensuring patient safety is more than just a priority — it’s a fundamental component of quality care. Establishing a strong patient safety culture within hospitals and health organizations can dramatically reduce errors, increase patient satisfaction and improve overall healthcare outcomes. But what exactly is a patient safety culture, and how can institutions cultivate it effectively?  This blog post explores the five key components that make up a robust patient safety culture, along with insights from the Agency for Healthcare Research and Quality (AHRQ) and The Joint Commission.  What is patient safety culture?  AHRQ defines patient safety culture as how an organization's culture supports and promotes patient safety. This can extend to multiple levels, from individual units to departments to system levels. The AHRQ patient safety culture survey encompasses the shared values, beliefs and norms of healthcare practitioners and staff that influence
Post a Comment
Read more